Brief: Carisma Therapeutics Provides Corporate Updates

Carisma Therapeutics

31/03/2025 23:35

March 31 (Reuters) - Carisma Therapeutics Inc CARM.O:

CARISMA THERAPEUTICS PROVIDES CORPORATE UPDATES

CARISMA THERAPEUTICS INC: TO EXPLORE STRATEGIC ALTERNATIVES TO ADVANCE LIVER FIBROSIS AND ONCOLOGY ASSETS AND REDUCE OPERATIONAL CASH BURN

CARISMA THERAPEUTICS INC: HAS REDUCED ITS WORKFORCE, RETAINING ONLY THOSE EMPLOYEES DEEMED ESSENTIAL TO PURSUE STRATEGIC ALTERNATIVES

CARISMA THERAPEUTICS INC: ESTIMATES THAT IT HAS CASH AND CASH EQUIVALENTS SUFFICIENT TO FUND ITS OPERATIONS INTO SECOND HALF OF 2025

CARISMA : MAY ENGAGE EXTERNAL ADVISORS TO SUPPORT EVALUATION OF STRATEGIC ALTERNATIVES, PREPARE FOR POTENTIAL WIND-DOWN OF OPERATIONS, IF NECESSARY

CARISMA THERAPEUTICS INC: HAS REDUCED OPERATIONS TO CORE FUNCTIONS NECESSARY TO SUPPORT THIS STRATEGIC REVIEW

CARISMA THERAPEUTICS INC: HAS PAUSED ALL RESEARCH AND DEVELOPMENT ACTIVITIES AT THIS TIME, PENDING OUTCOME OF REVIEW

Source text: ID:nPn7W7Rdxa

Further company coverage: CARM.O

 ((Reuters.Briefs@thomsonreuters.com;))